Latest Insider Transactions at Procter & Gamble CO (PG)
This section provides a real-time view of insider transactions for Procter & Gamble CO (PG). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of PROCTER & GAMBLE Co to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of PROCTER & GAMBLE Co's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 16
2018
|
Kathleen B Fish Chf Rsch, Dev & Innv Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
23,500
+28.38%
|
$1,551,000
$66.18 P/Share
|
|
Feb 15
2018
|
Juan Fernando Posada President - LA SMO |
SELL
Open market or private sale
|
Direct |
9,005
-29.88%
|
$738,410
$82.09 P/Share
|
|
Feb 15
2018
|
Juan Fernando Posada President - LA SMO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+24.92%
|
$660,000
$66.18 P/Share
|
|
Jan 31
2018
|
Kathleen B Fish Chf Rsch, Dev & Innv Officer |
SELL
Open market or private sale
|
Indirect |
10,192
-26.0%
|
$876,512
$86.97 P/Share
|
|
Jan 26
2018
|
Deborah P Majoras Chief Legal Officer & Secy |
SELL
Open market or private sale
|
Direct |
4,591
-9.15%
|
$399,417
$87.48 P/Share
|
|
Jan 24
2018
|
Marc S. Pritchard Chief Brand Officer |
SELL
Open market or private sale
|
Direct |
46,842
-31.21%
|
$4,168,938
$89.01 P/Share
|
|
Jan 24
2018
|
Marc S. Pritchard Chief Brand Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
46,842
+23.79%
|
$3,091,572
$66.18 P/Share
|
|
Dec 18
2017
|
Ernesto Zedillo Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,905
+3.94%
|
-
|
|
Dec 18
2017
|
Patricia A Woertz Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,905
+6.47%
|
-
|
|
Dec 18
2017
|
Margaret C Whitman Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,905
+9.97%
|
-
|
|
Dec 18
2017
|
W James Mcnerney Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,905
+2.61%
|
-
|
|
Dec 18
2017
|
Terry J Lundgren Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,905
+9.52%
|
-
|
|
Dec 18
2017
|
Scott D Cook Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,905
+2.5%
|
-
|
|
Dec 18
2017
|
Kenneth I Chenault Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,905
+4.96%
|
-
|
|
Dec 18
2017
|
Amy Chang Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,905
+50.0%
|
-
|
|
Dec 18
2017
|
Angela F Braly Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,905
+5.35%
|
-
|
|
Dec 18
2017
|
Francis S Blake Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,905
+15.76%
|
-
|
|
Dec 12
2017
|
Kenneth I Chenault Director |
BUY
Grant, award, or other acquisition
|
Direct |
307
+0.88%
|
-
|
|
Dec 12
2017
|
Terry J Lundgren Director |
BUY
Grant, award, or other acquisition
|
Direct |
362
+2.19%
|
-
|
|
Dec 12
2017
|
Francis S Blake Director |
BUY
Grant, award, or other acquisition
|
Direct |
307
+3.58%
|
-
|
|
Dec 12
2017
|
Scott D Cook Director |
BUY
Grant, award, or other acquisition
|
Direct |
348
+0.48%
|
-
|
|
Dec 12
2017
|
Angela F Braly Director |
BUY
Grant, award, or other acquisition
|
Direct |
348
+1.08%
|
-
|
|
Dec 12
2017
|
W James Mcnerney Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
390
+0.56%
|
-
|
|
Nov 29
2017
|
Carolyn M Tastad CEO - Health Care |
SELL
Bona fide gift
|
Direct |
225
-0.39%
|
-
|
|
Nov 03
2017
|
Steven D Bishop CEO - Health Care |
BUY
Bona fide gift
|
Indirect |
322
+16.0%
|
-
|
|
Nov 03
2017
|
Steven D Bishop CEO - Health Care |
SELL
Bona fide gift
|
Direct |
2,623
-2.79%
|
-
|